Share this article and save a life!
In the chaos of today’s emergency departments, critical cases are still missed. Until now.
The FDA just made history by granting Breakthrough Device Designation to Aidoc’s revolutionary multi-triage AI solution. This marks the first time the FDA has recognized an AI system capable of detecting multiple life-threatening conditions simultaneously within a single workflow. 🏥
Why this matters right now:
• Emergency departments are drowning. In 2025, over 25% of admitted patients wait 4+ hours for a bed, with many waiting beyond 24 hours.
• Physician and nurse shortages continue to worsen, creating dangerous bottlenecks in care delivery.
• Each minute counts for stroke, pulmonary embolism, and aortic dissection patients – conditions this AI can now flag instantly.
What makes this different from previous AI approvals is the comprehensive approach. Rather than requiring separate regulatory pathways for each clinical condition, the FDA is allowing parallel review of multiple indications in a single submission. This accelerates the path to implementation while maintaining rigorous safety standards.
The technology is built on CARE™, described as the first clinical-grade foundation model in healthcare with FDA-cleared solutions. It works through Aidoc’s aiOS™ platform, seamlessly integrating into existing hospital CT workflows.
Early adopters report that the system not only catches cases human radiologists might miss but also redistributes workloads to prioritize the most at-risk patients – effectively creating a safety net across the entire emergency care pathway.
This breakthrough comes at a critical moment for healthcare. With Aidoc’s technology already deployed in over 150 U.S. health systems and 1,600 hospitals worldwide, the potential impact is enormous.
The multi-triage approach could fundamentally transform how we manage emergency departments by providing consistent, 24/7 vigilance for the most dangerous conditions, regardless of staffing challenges or surging patient volumes.
What do you think? Is this the beginning of AI truly delivering on its promise in emergency medicine? Will this help solve the throughput crisis we’re facing in hospitals nationwide?
Share this article and save a life!
Author:
Jonathan Govette is a seasoned healthcare and technology executive with more than two decades of experience building, scaling, and advising digital health companies. He is the Co-Founder and CEO of Oatmeal Health, an AI-driven Lung Cancer Screening and Diagnostics company focused on expanding access to early detection for underrepresented populations, particularly patients served by Federally Qualified Health Centers and value-based health plans.
With a background in engineering, product development, and strategic partnerships, Jonathan has founded and led multiple health technology ventures across clinical care delivery, regulated medical software, and AI-enabled diagnostics. His work sits at the intersection of medicine, technology, and health equity, with a consistent focus on translating complex clinical problems into scalable, real-world solutions.
Jonathan has spent much of his professional life dedicated to improving outcomes for marginalized and underserved communities. He has designed and implemented frameworks that align clinical quality, reimbursement, and technology to sustainably advance health equity at scale. This mission is deeply personal and informs his leadership philosophy and long-term vision for healthcare transformation.
In addition to his operating experience, Jonathan is an author and long-time writer in the healthcare domain, with over 20 years of published work covering digital health, medical innovation, and healthcare systems. He is a frequent mentor to early-stage founders and regularly advises startups on product strategy, partnerships, and go-to-market execution in regulated healthcare environments.
Before entering industry full-time, Jonathan nearly pursued a career in medicine with an early path toward cardiothoracic surgery, an experience that continues to shape his clinical perspective and respect for frontline care delivery.
CEO | Oatmeal Health | AI Lung Cancer Startup | Engineer | Writer | Almost Became a Doctor (Cardiac Thoracic Surgeon) | 3x Health Tech Founder | Startup Mentor | Follow to share what I’ve learned along the way.
